Clinical Trials
3 trialsNCT00986440 2020-11-05
Study of CS-7017 in Colorectal Cancer Patients Who Have Achieved Disease Control Following First-Line Chemotherapy
Daiichi Sankyo
Phase 2 Terminated
NCT00603941 2020-09-16
A Phase 1/2 Study of CS7017, an Oral PPARγ Agonist, in Combination With Paclitaxel
Daiichi Sankyo
Phase 1/2 Terminated
NCT01504490 2017-02-14
Phase I Study of CS-7017 and Bexarotene
Georgetown University
Phase 1 Terminated